Lipidor Overview

  • Founded
  • 2009

Founded
  • Status
  • Public

  • Employees
  • 2

Employees
  • Stock Symbol
  • LIPI

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $0.75

  • (As of Thursday Closing)

Lipidor General Information

Description

Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections and atopic dermatitis.

Contact Information

Website
www.lipidor.se
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
STO
Primary Office
  • Karolinska Institutet Science Park
  • Fogdevreten 2
  • 171 65 Solna
  • Sweden

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lipidor Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.75 $0.75 $0.56 - $1.42 $21.7M 29M 19.4K -$0.11

Lipidor Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 21,439 19,815 41,177 38,199
Revenue 1,730 1,790 67 8
EBITDA (3,069) (2,477) (1,759) (1,458)
Net Income (3,074) (2,479) (1,757) (1,460)
Total Assets 4,448 6,080 8,031 3,027
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lipidor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lipidor‘s full profile, request access.

Request a free trial

Lipidor Patents

Lipidor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10363314-B2 Sprayable topical carrier and composition comprising phosphatidylcholine Active 14-Nov-2013 00000000 00
EP-3068437-B1 Sprayable topical carrier and composition comprising phosphatidylcholine Active 14-Nov-2013 00000000 0
EP-3068437-A4 Sprayable topical carrier and composition comprising phosphatidylcholine Granted 14-Nov-2013 00000000 0
US-20180311360-A1 Sprayable topical carrier and composition comprising phosphatidylcholine Granted 14-Nov-2013 00000000 0
JP-6563922-B2 Sprayable topical carrier and composition comprising phosphatidylcholine Active 14-Nov-2013 A61K8/34
To view Lipidor’s complete patent history, request access »

Lipidor Executive Team (7)

Name Title Board Seat Contact Info
Ola Holmlund Chief Executive Officer
Olle Holmertz Co-Founder, Board Member and Co-Chief Financial Officer
Michael Owens Chief Financial Officer
Anders Hagman Chief Development Officer
Jan Holmbäck Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Lipidor Board Members (6)

Name Representing Role Since
Karl Fredrik Sjövall Self Board Member 000 0000
Magnus Hedman Self Board Member 000 0000
Ola Flink Lipidor Chairman 000 0000
Olle Holmertz Lipidor Co-Founder, Board Member and Co-Chief Financial Officer 000 0000
Per Nilsson Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Lipidor Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lipidor Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lipidor‘s full profile, request access.

Request a free trial

Lipidor Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 15-Mar-2022 00000 (000 00000 Other Consumer Non-Durables 0000 0000
Emollivet 30-Jun-2020 Angel (individual) 00000 Other Consumer Non-Durables
To view Lipidor’s complete investments history, request access »